Actualités id6482.html
Awaiting development: Guidance and quality standards
Sun, 25 Feb 2024 07:16:00 GMT
Retifanlimab with platinum-based chemotherapy for treating inoperable, locally recurrent or metastatic squamous cell anal canal cancer untreated with systemic chemotherapy [ID6482] Technology ...